Sort
21,453 grants matching “tuberculosis”
Nontuberculous Mycobacteria Research Consortium
$244,537Charles L. Daley · National Jewish Health · R34 · FY2006 · AI
Development and Validation of Point-of-Care Tests for Tuberculosis
$244,504Marc D Porter · University Of Utah · U18 · FY2011 · FD
A novel c-di-AMP-based recombinant BCG vaccine
$244,500Guangchun Bai · Albany Medical College · R21 · FY2023 · AI
Structural mechanism of a DNA polymerase critical for developing antibiotic-resistance
$244,500Brian Anthony Kelch · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · AI
Structure of LAM in Relation to Biology and Biosynthesis
$244,440Colorado State University-Fort Collins · R21 · FY2002 · AI
Development of a phage-based nucleic acid amplification diagnostic for the rapid
$244,346Matthew Charles Mulvey · Sequella, Inc. · R43 · FY2008 · AI
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$244,250Ann R Falsey · University Of Rochester · UM1 · FY2021 · AI
A systematic method for Gain-of Function genetics in mycobacteria
$244,183Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · R21 · FY2021 · AI
Role of Macrophage Arginase in Anti-Bacterial Immunity
$244,169Peter J. Murray · St. Jude Children'S Research Hospital · R01 · FY2008 · AI
Role of Macrophage Arginase in Anti-Bacterial Immunity
$244,169Peter J. Murray · St. Jude Children'S Research Hospital · R01 · FY2009 · AI
Role of Nrf2 in immunotoxicity by food additives and environmental contaminants
$244,086Cheryl Elizabeth Rockwell · Michigan State University · R00 · FY2014 · ES
Project C: Transmission II Elimination
$244,076William J Moss · Johns Hopkins University · U19 · FY2022 · AI
The role and fate of Mtb storage lipids LCTAG and MWE
$244,067Georgiana E Purdy · Oregon Health & Science University · R21 · FY2020 · AI
Mechanisms of Cochlear Oxidative Stress Injury and Strategies to Protect Hearing
$244,026Michael J. Brenner · Southern Illinois University Sch Of Med · K08 · FY2012 · DC
Development of a Rapid Low-Cost Fecal-based TB Diagnostic for Children
$243,960Jeffrey D. Cirillo · Pulmonescence Diagnostics, Inc. · R41 · FY2020 · AI
Core B: BSL3 Advanced Technologies and Animal Infection Core
$243,901Sarah A Stanley · University Of California Berkeley · P01 · FY2024 · AI
Core B: BSL3 Advanced Technologies and Animal Infection Core
$243,900Sarah A Stanley · University Of California Berkeley · P01 · FY2023 · AI
Sterol/Hopanoid Biosynthesis: An Anti-TB Drug Target
$243,850Colorado State University-Fort Collins · R01 · FY2003 · AI
Sterol/Hopanoid Biosynthesis: An Anti-TB Drug Target
$243,850Colorado State University-Fort Collins · R01 · FY2004 · AI
DYNAMICS OF M. TUBERCULOSIS-SPECIFIC INNATE AND ADAPTIVE IMMUNITY DURING PREGNANCY AND POSTPARTUM IN WOMEN WITH HIV
$243,843Adriana Weinberg · University Of Colorado Denver · R21 · FY2022 · AI
Emerging and Re-Emerging Pathogens Research Training Program in DRC (EREP-RTP-DRC)
$243,824Jean-Jacques Tamfum Muyembe-Tamfum · Institut National De Recherche Biomedical · D43 · FY2025 · TW
Effect of HIV infection on M.tuberculosis granuloma formation and evolution
$243,750Larry S. Schlesinger · Texas Biomedical Research Institute · R21 · FY2020 · AI
Interactions between Environmental Microbiome, Maternal Immunity, Neonatal Epigenome and Respiratory Microbiome Development as Determinants of Asthma In Childhood
$243,663Donata Vercelli · University Of Arizona · R21 · FY2017 · AI
DNA Repair of Multiply Damaged Sites in Cells
$243,661Lynn Harrison · Louisiana State Univ Hsc Shreveport · R01 · FY2007 · CA
DNA Repair of Multiply Damaged Sites in Cells
$243,661Lynn Harrison · Louisiana State Univ Hsc Shreveport · R01 · FY2009 · CA